Compare ProShares Bitcoin ETF (BITO) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ProShares Bitcoin ETF vs IDEXX Laboratories, Inc. — how do they compare? ProShares Bitcoin ETF trades at $8.55, while IDEXX Laboratories, Inc. trades at $571.03 (market cap $46.22B). The key difference: IDEXX Laboratories, Inc. is trading nearer its 52-week high, ProShares Bitcoin ETF nearer its low. Which is the better fit depends on your goals.
| BITO | IDXX | |
|---|---|---|
Sector | Crypto-linked | Health |
52-Week High | $22.27 | $766.68 |
52-Week Low | $7.98 | $526.44 |
Market Cap | — | $46.22B |
Enterprise Value | — | $47.12B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BITO trades at $8.56, down 0.93% on the day, with a bearish technical outlook based on moving averages and key resistance at $9. Recent dividends of $0.01 per share were declared for mid-2026, but financial ratios like P/E and P/S are unavailable. News highlights investor skepticism toward Bitcoin futures ETFs amid crypto market weakness.
The outlook remains cautious due to structural underperformance versus spot Bitcoin ETFs and high implicit costs. Risks include fee drag, regulatory uncertainty, and correlation shifts with equities. Analyst sentiment is predominantly negative, with Sell ratings citing tactical utility over long-term holding appeal.
IDEXX Laboratories (IDXX) trades at $571.44, down 4.08% over the past day, amid a mixed technical and strong fundamental backdrop. The stock shows a bullish trend in moving averages but overbought RSI readings near 73. Recent Q2 2026 earnings beat expectations with 9% organic revenue growth, and the company raised full-year EPS guidance. Profitability remains robust with a 25.03% net income margin and 74.21% ROE.
The outlook is positive given strong earnings momentum, high analyst buy ratings, and a consensus price target of $683.33 implying ~20% upside. Risks include premium valuation multiples and potential market volatility. The stock presents a growth opportunity supported by durable competitive advantages in veterinary diagnostics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ProShares Bitcoin ETF
BITO offers exposure to Bitcoin returns primarily through Bitcoin futures contracts. It provides a regulated way for investors to trade Bitcoin performance within a traditional brokerage account without direct ownership.
Read more on BITO →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
